These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1450 related items for PubMed ID: 9237869
1. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869 [Abstract] [Full Text] [Related]
2. [Allo-cytotoxic T lymphocyte responses in corneal allografted mice treated with monoclonal antibodies to adhesion molecules]. Hori J, Isobe M, Mizuochi T, Yamagami S, Tsuru T. Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):582-6. PubMed ID: 8810232 [Abstract] [Full Text] [Related]
3. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. He Y, Mellon J, Apte R, Niederkorn JY. Invest Ophthalmol Vis Sci; 1994 Jul; 35(8):3218-25. PubMed ID: 7913917 [Abstract] [Full Text] [Related]
4. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H, Hamano K, Fukumoto T, Wood KJ, Esato K. J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [Abstract] [Full Text] [Related]
5. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. Isobe M, Suzuki J, Yagita H, Okumura K, Yamazaki S, Nagai R, Yazaki Y, Sekiguchi M. J Immunol; 1994 Dec 15; 153(12):5810-8. PubMed ID: 7527450 [Abstract] [Full Text] [Related]
15. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival. Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra BA. J Heart Lung Transplant; 2005 Sep 27; 24(9):1410-4. PubMed ID: 16143264 [Abstract] [Full Text] [Related]
16. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice. Xie B, Chen J, Wang F, Lan T, Wang Y, Xia J, Li Z, Xie Q, Huang R, Qi Z. Scand J Immunol; 2010 May 27; 71(5):345-52. PubMed ID: 20500685 [Abstract] [Full Text] [Related]
17. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival. Ritter T, Yang J, Dannowski H, Vogt K, Volk HD, Pleyer U. Transpl Immunol; 2007 Nov 27; 18(2):101-7. PubMed ID: 18005852 [Abstract] [Full Text] [Related]
18. Blockade of the OX40 ligand prolongs corneal allograft survival. Hattori T, Usui Y, Okunuki Y, Sonoda Y, Usui M, Takada E, Mizuguchi J, Yagita H, Okumura K, Akiba H, Takeuchi M. Eur J Immunol; 2007 Dec 27; 37(12):3597-604. PubMed ID: 18022861 [Abstract] [Full Text] [Related]
19. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK, Shelby J, Eichwald EJ. Transplantation; 1992 Apr 27; 53(4):849-57. PubMed ID: 1533070 [Abstract] [Full Text] [Related]
20. Characterization of cytokine profiles in corneal allograft with anti-adhesion therapy. Yamagami S, Isobe M, Tsuru T. Transplantation; 2000 Apr 27; 69(8):1655-9. PubMed ID: 10836377 [Abstract] [Full Text] [Related] Page: [Next] [New Search]